This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Beyond Meat (BYND) Announces Preliminary Results for Q3
by Zacks Equity Research
Beyond Meat's (BYND) third-quarter 2023 preliminary results suggest revenue declines of 9% and 26.5% on a year-over-year and sequential basis, respectively. Provides updates on its cost-saving actions.
COTY Set to Report Q1 Earnings: What Awaits the Stock?
by Zacks Equity Research
COTY's first-quarter results are likely to reflect gains across the Prestige and Consumer Beauty businesses. A focus on core priorities has been working well for Coty.
Pricing Aids Clorox's (CLX) Q1 Earnings Amid Cyberattack Woes
by Zacks Equity Research
Clorox's (CLX) Q1 results reflect the impacts of lower volume due to the recent cyberattack. However, results are largely offset by its pricing actions and cost-saving initiatives.
Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance
by Zacks Equity Research
Nu Skin (NUS) faces challenging y/y comparisons and macroeconomic hurdles in Q3, leading to a downward revision in its revenue and EPS projections for 2023.
Service Corporation (SCI) Q3 Earnings Beat, Sales Rise Y/Y
by Zacks Equity Research
Service Corporation's (SCI) third-quarter 2023 results reflect increased earnings and sales on growth across both segments.
Medifast (MED) Queues for Q3 Earnings: What Awaits the Stock?
by Zacks Equity Research
Medifast's (MED) third-quarter results are likely to reflect concerns surrounding customer acquisition amid a challenging landscape. However, a focus on growth plans bodes well.
Estee Lauder (EL) Lowers FY24 View Despite Q1 Earnings Beat
by Zacks Equity Research
Estee Lauder's (EL) first-quarter fiscal 2024 results reflect lower net sales and earnings. Management lowered the fiscal 2024 view on incremental external headwinds.
TreeHouse Foods (THS) to Post Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
TreeHouse Foods' (THS) third-quarter 2023 results are likely to reflect gains from solid demand for its snacking, beverages and grocery products, efficient pricing actions and cost-control measures.
Church & Dwight (CHD) Queues for Q3 Earnings: Is a Beat Likely?
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter results are likely to reflect gains from pricing, acquisitions and favorable demand amid high SG&A expenses.
Inter Parfums (IPAR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Inter Parfums (IPAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?
by Zacks Equity Research
e.l.f. Beauty's (ELF) strong business fundamentals, strategic acquisitions, focus on innovation and international expansion position it favorably ahead of its Q2 earnings release.
Will Inter Parfums (IPAR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Inter Parfums (IPAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Keurig Dr Pepper (KDP) Q3 Earnings Top Estimates, Sales Rise
by Zacks Equity Research
Keurig Dr Pepper (KDP) posts solid results in third-quarter 2023 on gains from continued brand strength and significant pricing.
Pilgrim's Pride (PPC) Q3 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Pilgrim's Pride (PPC) reports third-quarter 2023 results where revenues decline 2.4% year-over-year, owing to lackluster performance across the U.S. segment.
Simply Good Foods (SMPL) Earnings Beat in Q4, Sales Rise Y/Y
by Zacks Equity Research
Simply Good Foods (SMPL) posts higher sales for the fourth quarter of fiscal 2023 on increased sales across both segments.
Inter Parfums' (IPAR) Q3 Sales Increase on Product Launches
by Zacks Equity Research
Inter Parfums' (IPAR) sales increase year over year in third-quarter 2023 on effective product launches, brand extensions and continued traction of its legacy scents.
Archer Daniels (ADM) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Archer Daniels (ADM) reports third-quarter 2023 results, wherein revenues decline 12.1% y/y due to lackluster performances across the Ag Services & Oilseeds, and Carbohydrate Solutions segments.
The Estee Lauder Companies (EL) Hurt by Cost & Currency Woes
by Zacks Equity Research
The Estee Lauder Companies (EL) is operating amid volatile inflation levels. The company's solid international presence keeps it exposed to unfavorable currency fluctuations.
COTY Rides On Solid Beauty Product Demand, Headwinds Persist
by Zacks Equity Research
COTY benefits from its strength across businesses, strategic priorities and cost optimization programs. However, it has been grappling with rising operating costs and expenses.
Tyson Foods (TSN) & Protix to Build Insect Ingredient Facility
by Zacks Equity Research
Tyson Foods (TSN) to acquire a minority stake in Protix through a direct equity investment. It will also form a joint venture with the latter to construct and operate an insect ingredient facility.
Procter & Gamble (PG) Stock Gains on Q1 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble (PG) Q1 results benefit from strong top-line growth across segments, improved margin, and gains from cost-saving and productivity efforts.
Hain Celestial (HAIN) Stock Plunges 38% in a Year: Here's Why
by Zacks Equity Research
Hain Celestial (HAIN) grapples with several headwinds. Sluggishness in the company's North American unit is an added deterrent.
Energizer (ENR) Rides on Project Momentum, Risks Persist
by Zacks Equity Research
Energizer (ENR) benefits from its efforts to drive productivity, cost-saving actions and shareholder-friendly policies. Weakness in its battery and auto care businesses remains a concern.
Sysco (SYY) Displays Bright Prospects, Headwinds Persist
by Zacks Equity Research
Sysco (SYY) benefits from its diversified business structure, strategic priorities and acquired assets. However, it has been subject to product cost inflation for a while now.
Inter Parfums (IPAR) Blossoms on Solid Products, High Demand
by Zacks Equity Research
Inter Parfums (IPAR) has been gaining from its focus on launching new products and forming licensing agreements with renowned brands. Robust demand for fragrances is also working well.